Identification of the Genomic Etiology of Unexplained Congenital Problems in Pediatric Patients: First Reported Case With Coffin–Siris Syndrome and Sialuria From India Authors: Aparna Bhanushali, Archana Kawalakatt, Smita Kulkarni, Preethi Nair, Ankita Mali, Ashlesha Pradhan, Anirvan Chatterjee Published: 2026 ABSTRACT ABSTRACTCoffin–Siris syndrome (CSS) (OMIM:614608) is a rare genetic disorder characterized by global developmental delay (GDD), speech impediment, coarse facial features, and hypoplastic or absent fifth fingernails/toenails. Genetic variants in the SMARCB1 gene are associated with CSS, benign tumors (schwannomas), and rhabdoid tumor predisposition syndrome. Genetic variants in the GNE gene are associated with the autosomal dominant sialuria (OMIM#269921), a rare inborn error of metabolism resulting in high levels of free sialic acid. Here we present case reports of two siblings: patient 1 (10 years) and patient 2 (2 years). While both siblings showed GDD and dysmorphic features such as hypotelorism and large ears, patient #1 exhibited additional phenotypes. Whole exome sequencing identified a heterozygous pathogenic variant, NM_003073.5:c.1096C>T (p.Arg366Cys), in the SMARCB1 gene in both siblings. In addition, patient 1 harbored a heterozygous likely pathogenic variant, NM_005476.7:c.2086G>A (p.Val696Met), in the GNE gene, which was absent in patient 2. The co‐occurrence of the GNE variant may contribute to the increased severity of the phenotype in patient 1. This study is the first report worldwide of the co‐occurrence of two extremely rare disorders. These findings highlight the complexity of genomic contributions while also emphasizing the value of genomic sequencing for congenital problems. Key Clinical Message We report a rare case of Coffin–Siris syndrome caused by a SMARCB1 variant co‐existing with a GNE variant in an individual exhibiting greater neurodevelopmental impairment than an affected sibling with only the SMARCB1 variant, suggesting multilocus phenotypic modification and emphasizing the utility of comprehensive genomic evaluation. Coffin–Siris syndrome (CSS) is a congenital, rare genetic disorder characterized by global developmental delay (GDD), severe speech impediment, coarse facial features, and hypoplastic or absent fifth fingernails/toenails. Several genes in the BRG1/BRM‐associated factor (BAF), viz. ARID1A, ARID2, DPF2, PHF6, SMARCA2, SMARCA4, SMARCB1, SMARCC2, SMARCE1, as well as SOX transcription factors SOX4 or SOX11 [1] are associated with CSS. Genetic testing can confirm the diagnosis of CSS by identifying pathogenic variants in these genes (Vergano et al. [2]). Genotype–phenotype correlation has identified patterns, with variable manifestations and severity for different genes. Individuals with SMARCB1 mutation have a distinct subtype of CSS variant known as CSS type 3 (OMIM 614608), characterized by more severe neurodevelopmental phenotypes, language impairment, structural brain abnormalities, and severe ID. (Tsurusaki et al. [3], [1, 4, 5]). Interestingly, the SMARCB1 gene was first identified with rhabdoid tumor predisposition syndrome and benign schwannomatosis, and subsequently with CSS type 3. (Tsurusaki et al. [3]). Only missense variants are associated with CSS. ([5], Tsurusaki et al. [3], [6]) which may reflect a gain‐of‐function or dominant negative mechanism to be the causative effect, whereas rhabdoid tumor predisposition and schwannomatosis are primarily related to complete loss‐of‐function SMARCB1 mutations and hypomorphic SMARCB1 variants, which give rise to the synthesis of mutant proteins with residual function, respectively. Sialuria (OMIM#269921) is a rare inborn error of metabolism resulting in high levels of free sialic acid. The GNE {glucosamine (UDP‐N‐acetyl)‐2‐epimerase/N‐acetylmannosamine kinase} gene encodes the bifunctional enzyme, the UDP‐GlcNAc 2‐epimerase/ManNAc kinase; a defect in the feedback inhibition of this rate‐limiting enzyme in the sialic acid pathway causes the overproduction. The clinical features of sialuria mostly comprise developmental delay, mildly coarse features, hepatomegaly, and prolonged neonatal jaundice, classifying it as a mild disorder. Biallelic variants elsewhere in the GNE/MNK, which lead to decreased sialylation, are associated with GNE‐related myopathy [7, 8, 9]. Here we present case reports of two siblings: patient 1 (10 years) and patient 2 (2 years), along with parental studies. While both siblings showed GDD, dysmorphic features such as hypotelorism and large ears, the elder sibling (10 years) demonstrated greater phenotypic severity. Angelman syndrome was initially considered as a differential diagnosis because of the presence of developmental delay and early‐onset seizures. However, subsequent clinical evaluation, including normal electroencephalogram (EEG) findings and the presence of verbal communication, was not supportive of Angelman syndrome. Molecular testing by whole exome sequencing identified pathogenic variants in the SMARCB1 gene in both siblings, while the additional GNE variant was seen only in patient 1. To the best of our knowledge, this is the first‐ever case worldwide that has reported the co‐occurrence of two extremely rare disorders: Coffin–Siris syndrome and sialuria. Methodology EDTA‐whole blood (2 to 3 mL) was collected, and genomic DNA was extracted using the QiaGen Mini Amp kit (Qiagen Germany). NGS library preparation was done using the Twist Exome 2.0 Library Preparation kit (Twist Biosciences USA) following the manufacturer's instructions. The sequencing reads were assessed for quality, and the high‐quality reads were aligned to the GRCh38 reference genome. The aligned reads were processed and used for calling single‐nucleotide variants (SNVs) and small insertions/deletions (indels). The variants are classified and reported as per the ACMG/AMP sequence variant interpretation and reporting guidelines. Written informed consent was obtained from the parents of the probands for participation in the study and publication of clinical details and photographs/images. Case Report Patient 1 Clinical details: Patient 1 is a female child, born full term to a non‐consanguineous couple, with a normal delivery, with birth weight 2.75 kg. The pregnancy was uncomplicated; however, at 2 days of age, the patient developed a fever requiring admission to the neonatal intensive care unit, during which seizure episodes were noted. She was transferred to another hospital; there were no seizures afterwards, and she was treated for sepsis. On day 2, her blood sugar was 57 mg/dL (NR 70–140) and CRP 8.13 mg/dL (NR < 6.00). The patient underwent physiotherapy at six months to help with head holding. The patient had shown difficulty in latching and suckling and was given expressed breast milk. At 2 years. and 5 months, Brainstem Electric Response Audiometry (BERA) and electroencephalogram (EEG) were conducted. BERA demonstrated moderate‐to‐severe sensorineural hearing loss in the left ear, with normal hearing in the right ear. EEG indicated a normal sleep EEG record, no epileptic discharges seen, and no focal wave abnormality detected. The patient underwent occupational therapy (OT) and speech therapy from 3 to 5 years. The patient experienced another episode of seizure at 3 years. characterized by eye deviation (version) with tonic posturing, typically lasting ~30 s, with occasional prolonged events of up to 2–3 min. No associated breath‐holding spells were noted. Seizures required intermittent rescue therapy with intranasal midazolam, indicating ongoing seizure activity. Magnetic Resonance Imaging (MRI) was done at 4 years. age using T1W, T2W, FLAIR, and DW sequencing in multiple planes, which indicated mild paucity of white matter in both cerebral hemispheres with subtle ill‐defined hyperintense signals in bilateral external capsules and hypoplastic corpus callosum, especially in the posterior half of the body and splenium. Myelination was normal for the age of the patient, and mild prominence of the nasopharyngeal tissue was indicated as an incidental finding. Repeat EEG at 6 years. using the standard 10.20 international electrode placement system indicated no significant abnormality for the age. Developmental assessment revealed global developmental delay. Gross motor milestones were delayed, with neck control achieved at 8 months, independent sitting at 15 months, and independent walking at 19 months. Fine motor delay was evident, with pincer grasp attained at 17 months. Language development was delayed, with bisyllabic speech achieved at 2 years. Social development was affected, with the absence of stranger anxiety, and adaptive functioning was impaired, with toilet training achieved at 8 years of age. Neuropsychological evaluation: Neuropsychological evaluation was done at 7 years. 5 months by using the Malins intelligence scale for Indian children (MISIC), which provides measures of verbal IQ, performance IQ, and full‐scale IQ (FSIQ). The patient's FSIQ was found to be 79, indicating a borderline intelligence range. Additional tests done at 7 years. 10 months were: VSMS (Vineland Social Maturity Scale): Which indicated a raw score of 50, social age 4.5 years. Social Quotient of 51, pointing to a moderate delay in social functioningISAA (Indian Score for Assessment of Autism): The total score was 68, which is not indicative of autism spectrum disorder (ASD).Vanderbilt Parent Rating Scale: Indicated attention‐deficit hyperactivity disorder (ADHD‐combined type with oppositional defiant disorder). VSMS (Vineland Social Maturity Scale): Which indicated a raw score of 50, social age 4.5 years. Social Quotient of 51, pointing to a moderate delay in social functioning VSMS (Vineland Social Maturity Scale): Which indicated a raw score of 50, social age 4.5 years. Social Quotient of 51, pointing to a moderate delay in social functioning ISAA (Indian Score for Assessment of Autism): The total score was 68, which is not indicative of autism spectrum disorder (ASD). ISAA (Indian Score for Assessment of Autism): The total score was 68, which is not indicative of autism spectrum disorder (ASD). Vanderbilt Parent Rating Scale: Indicated attention‐deficit hyperactivity disorder (ADHD‐combined type with oppositional defiant disorder). Vanderbilt Parent Rating Scale: Indicated attention‐deficit hyperactivity disorder (ADHD‐combined type with oppositional defiant disorder). As reported by the parents to the counselor, the child primarily communicates using short, need‐based sentences and does not engage in spontaneous conversation. She does not establish eye contact but responds to her name being called. The parents noted frequent episodes of anger, an inability to differentiate between family members and strangers, self‐directed laughter, persistent fidgeting, and a tendency to leave the house unsupervised. The child was undergoing behavior therapy for several years, and as recorded at 8 years. 1 month, indicated sitting improved, coloring improved, attention improved, and understanding increased. The parents were advised schooling with shadow teachers and remedial education. Genetic Clinic: Evaluation by the clinical geneticist indicated large ears, hypotelorism, an elongated face, deep‐set eyes, an inappropriate smile, and gait ataxia (Figure 1A–C). Whole exome sequencing was advised. Clinical features observed in the affected siblings with SMARCB1‐associated Coffin–Siris syndrome. (Patient 1) Facial dysmorphism: Elongated face, small forehead, deep‐set eyes, thin hair, hypotelorism. (Patient 2) Large ear. (Patient 3) Hypoplastic fifth nail. (Patient 4) Facial dysmorphism: Sparse hair, small forehead, deep set eyes. Case Report Patient 2 Patient 2 is the sibling of patient 1, a female child, full term, normal delivery. Pediatric echocardiography performed at 2 months of age showed a small ostium secundum atrial septal defect (OS‐ASD) with left‐to‐right shunt. Left ventricle/right ventricle (LV/RV) function was normal. The left and right pulmonary arteries were confluent and adequately sized (4 mm each) without stenosis. There was no pericardial effusion, chamber dilatation, atrioventricular valve regurgitation (AVVR), pulmonary arterial hypertension (PAH), or patent ductus arteriosus (PDA). The interventricular septum was intact, with normal systemic and pulmonary venous drainage and no evidence of coarctation of the aorta. At 4 months of age, she was admitted to the hospital with multiple vomiting episodes and difficulty feeding. The physiotherapist's opinion indicated arching of the back and increased tone in extensions of the back with suspicion of a sensory issue, so feed thickening was advised. She developed paroxysmal events beginning at 7 months of age, reportedly triggered by a fall/traumatic event. The episodes were characterized by tonic posturing, eye rolling, and breath‐holding spells lasting approximately 2 min. Between 7 months and 3 years of age, approximately 5–6 such episodes were reported. No anti‐seizure medications were administered, and an electroencephalogram (EEG) evaluation was not performed. The semiology was suggestive of seizure‐like/paroxysmal neurological events. Developmental assessment indicated global developmental delay. Gross motor delay included delayed neck control (4 months), delayed sitting (with support at 8 months), delayed standing with support (14 months), and delayed independent walking (17 months). Fine motor development showed age‐appropriate scribbling (12 months). Language development demonstrated a mild delay in speech development (bisyllabic speech at 14 months). Comprehensive assessment of social, cognitive, and adaptive domains, as well as detailed neurological examination and vision assessment, was not available. Facial dysmorphism, including sparse hair, a small forehead, and deep‐set eyes, was noted (Figure 1D). No additional investigations have been done. The patient's current age is 2 years 4 months. Results The clinical details obtained from perusing the medical files of both cases and from the referring clinician are captured in Table 1. Exome analysis identified the heterozygous SMARCB1 variant NM_003073.5:c.1096C>T (p.Arg366Cys) in both siblings; patient 1 (chr22:23883681 C>T; C allele depth: 99 × [49%], T allele depth: 103 × [51%]), patient 2 (chr22:23883681 C>T; C allele depth: 149 × [55%], T allele depth: 121 × [45%]). The variant was classified as pathogenic based on ACMG criteria PS2, PM1, PM2, PM5, PP2, and PP3 [10]. The sequence change results in the substitution of arginine, a basic polar amino acid, by cysteine, a neutral, slightly polar amino acid, at codon 366. The variant is absent from population databases (gnomAD) and has previously been reported in individuals with clinical features of Coffin–Siris syndrome (PMID: 23906836) [4]. TABLE 1Comparative clinical, developmental, neurological, neuropsychological, imaging, and molecular findings in the affected siblings.DomainClinical ParameterPatient 1Patient 2 Demographic/Perinatal Details SexFemaleFemaleFamily historyNon‐consanguineous familyNon‐consanguineous familyPregnancy historyUncomplicatedUncomplicatedNeonatal historyFever and seizures requiring NICU admissionNo significant neonatal complications documented Genetic Findings Primary molecular diagnosis SMARCB1 NM_003073.5:c.1096C>T (p.Arg366Cys), pathogenic SMARCB1 NM_003073.5:c.1096C>T (p.Arg366Cys), pathogenicAdditional molecular finding GNE NM_005476.7:c.2086G>A (p.Val696Met), heterozygousAbsentSegregation analysis SMARCB1 variant absent in both parents; GNE variant inherited from father SMARCB1 variant absent in both parents Core Clinical Features Global developmental delayPresentPresentFeeding difficultiesPresentPresentHypoplastic fifth finger/toenailsPresentPresentCraniofacial dysmorphismPresentPresentNeuromuscular involvementPresentPresent Developmental Characteristics Neck holding8 months4 monthsSitting milestoneIndependent sitting at 15 monthsSitting with support at 8 monthsStanding milestoneNot documentedStanding with support at 14 monthsIndependent walking19 months17 monthsFine motor developmentPincer grasp at 17 monthsScribbling at 12 monthsLanguage developmentBisyllabic speech at 2 yearsBisyllabic speech at 14 monthsSocial developmentAbsence of stranger anxietyDetailed assessment unavailableAdaptive functioningToilet training achieved at 8 yearsDetailed assessment unavailable Neurological Manifestations Seizures/paroxysmal eventsNeonatal seizures reportedPresentAge at onsetNeonatal period7 monthsClinical semiologySeizures associated with neonatal encephalopathyEpisodes triggered following falls, characterized by tonic posturing, eye rolling, and breath‐holding spells lasting ~2 minFrequency of episodesIntermittent recurrent seizuresApproximately 5–6 episodes between 7 months and 3 yearsEEG findingsNormal EEG at 2 years 5 monthsEEG not performedAnti‐seizure medicationIntermittent rescue therapy with intranasal midazolamNot administered Hearing/Sensory Evaluation Hearing assessmentBrainstem evoked response audiometry (BERA) showed moderate‐to‐severe sensorineural hearing loss in the left ear, with normal right ear findingsNot performedVision assessmentNot documentedNot available Cardiac Evaluation Echocardiography findingsNot availableSmall ostium secundum atrial septal defect (OS‐ASD) with left‐to‐right shuntVentricular functionNot availableNormal left ventricle/right ventricle (LV/RV) functionAdditional cardiac abnormalitiesNot availableNo pulmonary arterial hypertension, PDA, chamber dilatation, or coarctation of the aorta Neuropsychological Evaluation Formal neuropsychological assessmentPerformed (MALIN'S scale, VSMS, Vanderbilt parent rating scale)Not availableCognitive/behavioral concernsDevelopmental and adaptive impairmentLimited assessment available Phenotypic Interpretation Relative developmental severityMore pronounced developmental impairmentComparatively milder developmental involvementPossible contribution of multilocus variationPossible modifying role of co‐existing GNE variantNot applicable Comparative clinical, developmental, neurological, neuropsychological, imaging, and molecular findings in the affected siblings. Structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability indicate that this missense variant is expected to disrupt SMARCB1 protein function. The GNE variant c.2086G>A (p.Val696Met) identified in patient 1(chr9:36217448 C>T C: 216 [54%]; T: 182 [46%]) has been classified as likely pathogenic based on the ACMG criteria, PM2, PM1_Supporting, PP2, PP3, PP5. The variant results in a conservative amino acid change, and in‐ silico tools predict a damaging effect. The GNE c.2086G>A variant shows an allele count of 1203 out of 1,614,208 alleles in gnomAD v4.1.1, corresponding to an overall allele frequency of 0.0007453, with 12 homozygotes reported in the dataset. The value ‘0.012’ represented the allele frequency in the South Asian subpopulation. Parental exome analysis did not identify the SMARCB1 variant in either parent. The variant was absent in the father (chr22:23883681 C>T; C allele depth: 219 × [100%]) and mother (chr22:23883681 C>T; C allele depth: 205 × [100%]), raising the possibility of parental gonadal mosaicism. The GNE variant was seen in the father in heterozygous form (chr9:36217448 C>T C: 184 {49%}; T: 193 {51%}) but was absent in the mother (chr9:36217448 C>T C: 368 × {100%}). Discussion The burden of genetic disorders is high in India, particularly due to the unique population structure, high degree of consanguinity, and inbreeding. Till recent times, many of the cases would be undiagnosed, but with growing awareness of next‐generation sequencing, particularly whole‐exome sequencing (WES) and lowering costs, the diagnostic odyssey has been significantly reduced. Here, we present case reports from 2 siblings, where WES resulted in diagnostic resolution at 10 years for the elder sibling. This case is unique because two extremely rare disorders have been identified in one of the siblings, patient 1 (10 years). In the current study, both siblings were identified with a heterozygous pathogenic variant in the SMARCB1 gene. This mutation was previously identified as a de novo missense mutation in an individual with Nicolaides–Baraitser (NCBRS) syndrome, reclassified as CSS [4]. Interestingly, all the mutations in the comprehensive molecular study by [4] lie in exons 8 and 9, which encode for the highly conserved sucrose/non‐fermenting domain (SNF5) of the protein. The clinical manifestations for SMARCB1‐associated CSS have been varied; in most studies where ID was evaluated, the spectrum ranged from severe Tsurusaki et al. [3]; [1], to moderate [11] and mild [12]. Developmental motor delay was seen in all the 3 cases studied by Tsurusaki et al. [6]. Similarly, Mannino et al. [13] reported 8 SMARCB1 cases to exhibit developmental delay, with a mean age of 30 months for walking acquisition and a first word mean age of 12 months. The developmental profile observed in the present siblings is consistent with the reported phenotypic spectrum of SMARCB1‐associated Coffin–Siris syndrome. Additional clinical findings in the present cohort also overlap with previously reported SMARCB1‐associated phenotypes. In the study of Wieczorek et al. [4], of the 9 patients, 7 presented with developmental delay, the typical craniofacial gestalt, hypoplastic or absent fifth finger and toenails, and feeding difficulties, while hearing impairment and seizures were present in 5 and 4 cases, respectively. Global developmental delay, ID (n = 6), delayed motor milestones (n = 3), and ASD (n = 2) have been indicated by Vasko et al. [14], in their study of 14 patients with SMARCB1. In our case report, individual 1 exhibited feeding difficulties, hearing impairment, seizures, and developmental delay, whereas neuromuscular defects were observed in individual 2 (hearing impairment and imaging tests not done). Consistent with these observations, the older sibling in the present study exhibited feeding difficulties, hearing impairment, seizures, and developmental delay, while the younger sibling demonstrated developmental delay, ASD, and seizure‐like/paroxysmal neurological events. Seizures are a recognized feature of Coffin–Siris syndrome; however, the age at onset and clinical spectrum remain variable. In the present cohort, both patients demonstrated neonatal‐onset seizures with persistence beyond the neonatal period, suggesting an early and sustained neurological involvement. Neonatal‐onset seizures are not consistently emphasized as a defining feature within the Coffin–Siris spectrum, particularly in association with variants in the SMARCB1 gene. The observation of early‐onset epilepsy in both patients expands the phenotypic spectrum and highlights the need to consider SWI/SNF‐related disorders in the differential diagnosis of neonatal epilepsies, especially when accompanied by developmental delay and dysmorphic features. Interestingly, in a fetal cohort of 44 patients with variants in CSS‐associated genes, SMARCB1‐associated prenatal anomalies were seen only in 13% (6/44) cases, with IUGR being most common [15]. The authors hypothesize that prenatally non‐mosaic variants lead to embryonic lethality in other CSS‐related genes, such as ARID1A, and that may be the reason for the lower frequency postnatally of the ARID1A variants. While in the case of the SMARCB1 gene, IUGR, a non‐specific prenatal anomaly, is most frequent. This could be the reason for the higher frequency of the SMARCB1‐associated CSS postnatally, which incidentally is associated with a more severe presentation. However, recent findings by Apicella et al. [16] have further expanded the clinical spectrum associated with SMARCB1 variants by describing an individual with normal intelligence and only mild neuropsychological deficits. This represents a deviation from the till‐date reported association of SMARCB1‐related Coffin–Siris syndrome with significant neurodevelopmental impairment and highlights the variable clinical expressivity. This also leads us to question if the phenotypes are mutation‐specific and if early intervention in terms of learning, cognition, and psychological support can change the trajectory for these individuals, enabling a better quality of life. Recent studies have identified distinct peripheral blood DNA methylation episignatures across multiple BAF‐complex–related disorders involving ARID1B, SMARCB1, SMARCA4, and SMARCA2, suggesting a potential complementary role for episignature analysis in molecular classification and variant interpretation, particularly in diagnostically challenging cases [17]. Although not currently part of routine clinical evaluation, these findings provide additional insights into the shared functional mechanisms underlying BAF‐complex–related disorders. Sialuria (OMIM #269921) is an inborn error of metabolism that leads to high levels of free sialic acid due to dominant mutations in the GNE gene. The first case of sialuria was identified in the year 1968; since then, only 11 cases have been identified to date [18, 19], with the case reported in this study being the 12th. In the report compiled by [8] of six patients, the developmental ages or IQ were low for all patients. However, later in childhood, neurodevelopment or neuromotor activities were unaffected or only mildly impaired. Sialuria was thus indicated to be a mild condition, the diagnosis of which can be confirmed by increased urinary excretion of NeuAc. The two factors that it is a mild phenotype and the fact that assay for urinary levels of free NeuAc is not a routine laboratory procedure may contribute to its prevalence being underestimated. Interestingly, the same GNE variant identified in the present study, NM_005476.7:c.2086G>A (p.Val696Met), has previously been reported by Gowda et al. in an Indian patient who was reverse phenotyped and biochemically confirmed to have sialuria, with elevated urinary total and free N‐acetylneuraminic acid levels. That individual also presented with global developmental delay and seizures beginning at 6 months of age, requiring anti‐seizure therapy. Although this prior report supports the possible clinical relevance of the identified GNE variant, the absence of biochemical confirmation in the present family and the presence of the variant in an apparently unaffected father warrant cautious interpretation. The phenotype of the father has been almost unaffected. The father has been an autorickshaw driver and has not been able to move up the social ladder, while the other siblings of the father are relatively better placed. Having said that, we acknowledge that there would be many factors and that socioeconomic status would not be a true barometer for determining the effect of sialuria. In this case, we feel the need to highlight this aspect because comparatively greater developmental impairment observed in the sibling carrying the co‐existing GNE variant raises the possibility that multilocus genomic variation may have influenced phenotypic severity. If an additive effect is observed due to the combined presence. It would also be very interesting to have a longitudinal monitoring of both siblings in our study to see the effects. This study is also unique in that it is only the second case of an adult reported carrying sialuria‐associated variants. Champaigne et al. [18] reported an adult female diagnosed following evaluation of her affected child, with subsequent identification of intrahepatic cholangiocarcinoma (IHCC). Follow‐up of that family also documented hepatomegaly and fatal IHCC in the maternal grandmother, thereby expanding the clinical spectrum reported in association with sialuria. Although the pathogenic contribution of the GNE variant in the present family remains uncertain in the absence of biochemical confirmation, these observations underscore the importance of longitudinal clinical follow‐up and further biochemical evaluation, including urinary free N‐acetylneuraminic acid (NeuAc) analysis, in individuals carrying suspected sialuria‐associated variants. Summary This study is the first report worldwide of the co‐occurrence of two extremely rare disorders: Coffin– Siris syndrome and sialuria. “The identification of the same pathogenic SMARCB1” variant in both affected siblings, despite its absence in parental peripheral blood samples, raises the possibility of parental gonadal mosaicism. The observation of early‐onset epilepsy in both patients expands the phenotypic spectrum and highlights the need to consider SWI/SNF‐related disorders in the differential diagnosis of neonatal epilepsies. In addition, the comparatively greater developmental impairment observed in patient 1 raises the possibility that the co‐occurring GNE variant may contribute to phenotypic variability. These findings also highlight the complexity of genomic contributions while also emphasizing the value of genomic sequencing for congenital problems. Author Contributions Aparna Bhanushali: writing – original draft. Archana Kawalakatt: writing – original draft. Smita Kulkarni: writing – original draft. Preethi Nair: writing – original draft. Ankita Mali: writing – original draft. Ashlesha Pradhan: writing – original draft. Anirvan Chatterjee: writing – original draft. Funding The authors have nothing to report. Ethics Statement Written informed consent was obtained from the parents. Conflicts of Interest The authors declare no conflicts of interest.